U.K.'s CGT Catapult Partners with Freeline to Build Gene Therapy Manufacturing Platform

The Cell and Gene Therapy (CGT) Catapult said today it will partner with Freeline Therapeutics to build the gene therapy developer's proprietary manufacturing platform at the CGT Catapult’s large-scale GMP manufacturing center in Stevenage, Hertfordshire, U.K.CGT Catapult is a U.K. government initiative created to advance the growth of the cell and gene therapy industry by bridging the gap between scientific research and large-scale commercialization. The U.K. has